Vimarsana
Biggest News Aggregation in the World

Small Anim Pract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Small Anim Pract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Small Anim Pract Today - Breaking & Trending Today

Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs - Vimarsana News

Zoetis Announces U.S. FDA Approval of Librela™ (bedinvetmab injection) to Control Osteoarthritis (OA) Pain in Dogs

Published: May 5, 2023

Librela™ is the first and only injectable monoclonal antibody treatment for the control of canine OA pain approved in the United States Zoetis continues to advance innovation with a new... | May 5, 2023

Source: marketscreener.com
Related Topics:
New ZealandUnited KingdomUnited StatesDuncan LascellesLaura OlsenAnaesth AnalgZoetis IncCarolina State UniversityDrug AdministrationGlobal Pain CouncilAnimal Health Market AnalysisPettrak Us Pain Factored NationalEuropean Medicines AgencyZoetis ServicesProfessor Of Translational Research In PainUnmet NeedSenior Vice PresidentNerve Growth FactorTranslational ResearchNorth Carolina State UniversityClinical Experience ReportedSouth AmericaPrescribing InformationLooking StatementsAnnual Report
Jaguar Health, Inc.: Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - Vimarsana News

Jaguar Health, Inc.: Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Published: January 4, 2022

The Canalevia.com website, a resource for veterinarians and dog owners, is now liveCanalevia-CA1 is the first and only treatment for chemotherapy-induced diarrhea (CID) in dogs to receive any type of approval

Source: finanznachrichten.de
Related Topics:
Michael GuyPuerto VallartaPeter HodgeJaguar HealthVeterinary Cancer SocietyJaguar Animal HealthJaguar Health IncNapo PharmaceuticalsExchange CommissionNapo Pharmaceuticals IncAnimal Health Commercial PortfolioChip WhitlowMarketing DirectorAnimal Health CommercialVice PresidentLas Vegas MarchVeterinary Cancer Society Mid Year ConferenceMexico AprilMinor UseMajor SpeciesAnimal HealthNapo TherapeuticsSmall Anim Pract
Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - Vimarsana News

Jaguar Health Launches Canalevia-CA1 (Crofelemer) for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs

Published: January 4, 2022

Press release content from Accesswire. The AP news staff was not involved in its creation.

Source: apnews.com
Related Topics:
Michael GuyPuerto VallartaJaguar HealthVeterinary Cancer SocietyJaguar Animal HealthJaguar Health IncPeter Hodge Jaguar Health IncNapo PharmaceuticalsExchange CommissionNapo Pharmaceuticals IncAnimal Health Commercial PortfolioChip WhitlowMarketing DirectorAnimal Health CommercialVice PresidentLas Vegas MarchVeterinary Cancer Society Mid Year ConferenceMexico AprilMinor UseMajor SpeciesAnimal HealthNapo TherapeuticsSmall Anim PractPeter HodgePrescription Drugs